Work

ClpC1 Modulating Ohmyungsamycin A and Ecumicin Natural Product Analogues are Potent Antimycobacterials

Year: 2025

Type: article

Source: ACS Infectious Diseases

DOI: 10.1021/acsinfecdis.5c00689

Authors: Paige M. E. Hawkins, Max J. Bedding, David M. Hoi, Isabel K. Barter, Chen-Yi Cheung, Stefan H. Oehlers, Gregory M. Cook, Tim Clausen, Warwick J. Britton, Richard J. Payne

Institutions: The University of Sydney, ARC Centre of Excellence for Innovations in Peptide and Protein Science, Research Institute of Molecular Pathology, University of Otago, Agency for Science, Technology and Research, Centenary Institute, Infectious Diseases Labs, Royal Prince Alfred Hospital

Language: English

Topic: Chemical Synthesis and Analysis

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: University of Sydney, National Health and Medical Research Council, Health Research Council of New Zealand

Awards: Hijacking the mycobacterial protein degradation system for new drugs against tuberculosis, Centre of Research Excellence in Tuberculosis Control on both sides of our border.

OpenAlex ID: W4415469734

FWCI: 0.522

Cites: 31

Cited by: 2

Related to: